Vera Therapeutics clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
Atacicept in Subjects With IgA NephropathyNCT04716231AtaciceptActive not recruiting2025-05-15Actual

Phase 2 4 trials

TrialDrugs studiedStatusPrimary completion
Atacicept in Multiple Glomerular DiseasesNCT06983028AtaciceptRecruiting2027-11Estimated
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of AtaciceptNCT06674577Atacicept 150 mgEnrolling by invitation2031-05-21Estimated
Monthly Dosing of Atacicept in IgANNCT07020923AtaciceptActive not recruiting2026-09-22Actual
A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant RecipientsNCT04294472MAU868Completed2022-02-10Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
Monthly Dosing of Atacicept in IgAN

NCT07020923 · Vera Therapeutics, Inc.

· 2 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Sep 2026. After: 22 Sep 2026.

Check registry source
Atacicept in Subjects With IgA Nephropathy

NCT04716231 · Vera Therapeutics, Inc.

· 3 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from baseline in urine protein to creatinine ratio (UPCR) Description: UPCR based on 24 hour urine collection Time frame: 36 Weeks. After: Measure: Percentage Change From Baseline in Urine Protein to Creatinine Ratio (UPCR) Description: Percentage reduction in UPCR was obtained from geometric mean ratios. The natural log-transformed ratio of UPCR to its baseline value was analyzed using a Mixed Model for Repeated Measures (MMRM), adjusted by baseline variables specified in the Statistical Analysis Plan (SAP), including data from baseline up to Week 36 during the Double-Blind period. Time frame: 36 Weeks.

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 376 participants (planned). After: 428 participants (actual).

Check registry source